Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
IBEX Technologies Inc banner

IBEX Technologies Inc
XTSX:IBT

Watchlist Manager
IBEX Technologies Inc Logo
IBEX Technologies Inc
XTSX:IBT
Watchlist
Price: 1.44 CAD Market Closed
Market Cap: CA$35.3m
Write Note Create Alert Ask AI

Gross Margin

71.3%
Current
Improving
by 1.4%
vs 3-y average of 69.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
71.3%
=
Gross Profit
CA$5.6m
/
Revenue
CA$7.8m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
71.3%
=
Gross Profit
CA$5.6m
/
Revenue
CA$7.8m

Peer Comparison

Country Company Market Cap Gross
Margin
CA
IBEX Technologies Inc
XTSX:IBT
35.5m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
403.9B USD
Loading...
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
204.6B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
185.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
AU
CSL Ltd
ASX:CSL
70.5B AUD
Loading...

Market Distribution

Higher than 87% of companies in Canada
Percentile
87th
Based on 4 108 companies
87th percentile
71.3%
Low
-10 058.3% — 20.4%
Typical Range
20.4% — 50.5%
High
50.5% — 717.4%
Distribution Statistics
Canada
Min -10 058.3%
30th Percentile 20.4%
Median 33.6%
70th Percentile 50.5%
Max 717.4%

Other Profitability Ratios

IBEX Technologies Inc
Glance View

Market Cap
35.3m CAD
Industry
Biotechnology

IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. The Company’s subsidiaries also include Technologies IBEX R&D Inc., IBEX Technologies Corporation and Bio-Research Products Inc. (BRP).

IBT Intrinsic Value
Not Available
What is Intrinsic Value?

See Also

Summary
IBT intrinsic value, competitors valuation, and company profile.
DCF Valuation
IBT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IBT stock valuation using valuation multiples.
Wall Street Estimates
IBT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IBT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
71.3%
=
Gross Profit
CA$5.6m
/
Revenue
CA$7.8m
What is IBEX Technologies Inc's current Gross Margin?

The current Gross Margin for IBEX Technologies Inc is 71.3%, which is above its 3-year median of 69.9%.

How has Gross Margin changed over time?

Over the last 3 years, IBEX Technologies Inc’s Gross Margin has increased from 56.4% to 71.3%. During this period, it reached a low of 56.4% on Oct 31, 2020 and a high of 71.3% on Nov 1, 2023.

Back to Top
ALPHA SPREAD
Follow us
Join more than 320,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.